Corbus Pharmaceuticals Holdings, Inc. Stock Performance

Open $5.20	Prev. Close $5.27	Circuit Range N/A
Day Range $5.18 - $5.59	Year Range $5.14 - $19.84	Volume 37,362
Average Traded $5.40

Corbus Pharmaceuticals Holdings, Inc. Share Price Today

As of 10 October 2026, Corbus Pharmaceuticals Holdings, Inc.'s share price is $5.38. The stock opened at $5.20, compared to its previous close of $5.27. During today's trading session, Corbus Pharmaceuticals Holdings, Inc.'s share price traded between $5.18 and $5.59, with an average price of $5.39. Over the past 52 weeks, the stock has recorded a high of $19.84 and a low of $5.14. In terms of performance, Corbus Pharmaceuticals Holdings, Inc.'s share price has declined by 45.71% over the last six months and is down 55.50% on a year-on-year basis.

Corbus Pharmaceuticals Holdings, Inc. Share Price Chart

$5.18$5.59

Corbus Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap $71.65M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-5.27	Revenue (TTM) $0.00	Return On Equity (TTM) -99.67%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY -50.13%

Corbus Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$23.34	-$20.56	-$22.97	-$35.04
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	11.91%	-11.72%	-52.55%

Corbus Pharmaceuticals Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$42.35	-$44.60	-$40.21	-$78.54
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-5.31%	9.84%	-95.32%

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Corbus Pharmaceuticals Holdings, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$6.76	$5.39	-20.72%
Sep 2026	$10.66	$6.80	-38.91%
Aug 2026	$8.86	$11.14	+23.92%
Jul 2026	$9.30	$8.99	-4.31%
Jun 2026	$7.74	$9.39	+19.15%
May 2026	$9.70	$7.88	-20.43%
Apr 2026	$10.11	$9.91	+5.65%
Mar 2026	$8.39	$9.38	+10.09%
Feb 2026	$8.33	$8.52	+3.21%
Jan 2026	$8.19	$8.26	+1.68%
Dec 2025	$11.27	$8.12	-29.18%
Nov 2025	$12.28	$11.46	-5.17%

CRBP Share Price FAQs

What is Corbus Pharmaceuticals Holdings, Inc. share price today?

Corbus Pharmaceuticals Holdings, Inc. share price today is $5.38 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Corbus Pharmaceuticals Holdings, Inc. stock?

The 52 week high of Corbus Pharmaceuticals Holdings, Inc. stock is $19.84, while the 52 week low is $5.14 as of 10 Oct '26.

What is CRBP's market capitalisation today?

CRBP market capitalisation is $71.65M as of October 10, 2026, at 3:01 am IST.

What is CRBP's net income for the last quarter?

CRBP's net income for the last quarter is -35.04B USD.

What is the 5 year returns of CRBP?

The 5 year returns of CRBP is -82.33% as on 10 Oct '26.

What is the high & low stock price of CRBP today?

CRBP stock price hit a high of $5.59 and low of $5.18 as of 10 Oct '26.

Can I buy CRBP shares in India?

Yes. You can buy CRBP in India by opening an international trading account.